Formation and activation by phosphorylation of activin receptor complexes

Molecular Endocrinology

Volumn 10, Issue 4, 1996, Pages 367-379

  Willis, Susan A ^a   Zimmerman, Cole M ^a   Li, Li ^a   Mathews, Lawrence S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; GROWTH FACTOR RECEPTOR; PROTEIN SERINE KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS; ACTIVIN RECEPTORS, TYPE I; ACTIVINS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; GROWTH SUBSTANCES; INHIBINS; KINETICS; LUCIFERASES; METHIONINE; MICE; MINK; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; SEQUENCE TAGGED SITES; SERINE; SIGNAL TRANSDUCTION; THREONINE;

ANIMALIA; MUSTELA VISON;

EID: 0029985652     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.4.367     Document Type: Article

References (57)

1. Vale W, Hsueh A, Rivier C, Yu J 1990 The inhibin/activin family of hormones and growth factors. In: Sporn MA, Roberts AB (eds) Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology. Springer-Verlag, Berlin, pp 211-248
2. Kingsley DM 1994 The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146
3. Mathews LS 1994 Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15:310-325
4. Mathews LS, Vale WW 1991 Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982
5. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF 1992 Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
6. Mathews LS, Vale WW, Kintner CR 1992 Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 255:1702-1705
7. Attisano L, Wrana JL, Cheifetz S, Massagué J 1992 Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108
8. Liu F, Ventura F, Doody J, Massagué J 1995 Human type II receptor for bone morphogenic proteins (BMPs). Mol Cell Biol 15:3479-3486
9. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, Ten Dijke P, Heldin CH, Miyazono K 1995 Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636
10. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS 1995 Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270:22522-22526
11. Ebner R, Chen R-H, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R 1993 Cloning of a type I TGF-β receptor and its effects on TGF-β binding to the type II receptor. Science 260:1344-1348
12. Ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K 1993 Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887
13. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, Miyazono K 1993 Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75:681-692
14. Tsuchida K, Mathews LS, Vale WW 1993 Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci USA 91:11242-11246
15. Ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH 1994 Characterization of type I receptors for transforming growth factor-β and activin. Science 264:101-104
16. Georgi LL, Albert PS, Riddle DL 1990 daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 61:635-645
17. Estevez M, Attisano L, Wrana JL, Albert PS, Massagué J, Riddle DL 1993 The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature 365:644-649
18. Ruberte E, Marty T, Nellen D, Affolter M, Basler K 1995 An absolute requirement for both the type II and type I receptors, punt and thick veins, for dpp signaling in vivo. Cell 80:889-897
19. Letsou A, Arora K, Wrana JL, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J, O'Connor MB 1995 Drosophila dpp signaling is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGFβ family. Cell 80:899-908
20. Xie T, Finelli AL, Padgett RW 1994 The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-β superfamily. Science 263:1756-1759
21. Penton A, Chen Y, Staehling-Hampton K, Wrana JL, Attisano L, Szidonya J, Cassill JA, Massagué J, Hoffmann FM 1994 Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 78:239-250
22. Nellen D, Affolter M, Basler K 1994 Receptor serine/ threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic. Cell 78:225-237
23. Brummel TJ, Twombly V, Marques G, Wrana JL, Newfeld SJ, Attisano L, Massagué J, O'Connor MB, Gelbart WM 1994 Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell 78:251-261
24. Childs SR, Wrana JL, Arora K, Attisano L, O'Connor MB, Massagué J 1993 Identification of a Drosophila activin receptor. Proc Natl Acad Sci USA 90:9475-9479
25. Wrana JL, Tran H, Attisano L, Arora K, Childs SR, Massagué J, O'Connor MB 1994 Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol 14:944-950
26. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K 1994 Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-8
27. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, et a 1994 Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-74
28. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang X-F 1994 A transforming growth factor-β type I receptor that signals to activate gene expression. Science 263:87-89
29. Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J 1994 Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol 14:3810-21
30. Attisano L, Cárcamo J, Ventura F, Weis FMB, Massagué J, Wrana JL 1993 Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680
31. Yamashita H, Ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K 1995 Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217-226
32. Mathews LS, Vale WW 1993 Characterization of type II activin receptors: binding, processing and phosphorylation. J Biol Chem 263:19013-19018
33. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massagué J 1992 TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014
34. Gonzalez-Manchon C, Vale W 1989 Activin A, inhibin and TGF-β modulate growth of two gonadal cell lines. Endocrinology 125:1666-1672
35. Wilson IA, Niman HL, Houghten RA, Cherenson AR, Connolly ML, Lerner RA 1984 The structure of an antigenic determinant in a protein. Cell 37:767-778
36. DePaolo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198:500-512
37. Tsuchida K, Vaughan JM, Wiater EM, Gaddy-Kurten D, Vale WW 1995 Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology 136:5493-5503
38. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG 1994 Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970
39. van der Geer P, Hunter T, Lindberg RA 1994 Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251-337
40. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J 1994 Mechanism of activation of the TGF-beta receptor. Nature 370:341-347
41. Ventura F, Doody J, Liu F, Wrana JL, Massagué J 1994 Reconstitution and transphosphorylation of TGF-beta receptor complexes. EMBO J 13:5581-5589
42. Chen F, Weinberg RA 1995 Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor βreceptor kinases. Proc Natl Acad Sci USA 92:1565-1569
43. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M 1995 Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J Biol Chem 270:12235-12241
44. Wieser R, Wrana JL, Massagué J 1995 GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14:2199-2208
45. Franzén P, Heldin CH, Miyazono K 1995 The GS domain of the transforming growth factor-β type I receptor is important in signal transduction. Biochem Biophys Res Commun 207:682-689
46. Zimmerman CM, Mathews LS 1996 Activin receptors: cellular signaling by receptor serine kinases. In: Chapman KE, Jackson SE, Wilkinson D (eds) Extracellular Regulators of Differentiation. Portland Press, London, vol 61, in press
47. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P 1992 Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. MoI Cell Biol 12:240-247
48. Tyers M, Tokiwa G, Nash R, Futcher B 1992 The Cln3-Cdc28 kinase complex of S. cerevisiae is regulated by proteolysis and phosphorylation. EMBO J 11:1773-1784
49. Wieser R, Attisano L, Wrana JL, Massagué J 1993 Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 13:7239-7247
50. Mathews LS, Vale WW 1993 Molecular and functional characterization of activin receptors. Receptor 3:173-181
51. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR 1988 Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1-10
52. Feilotter HE, Hannon GJ, Ruddell CJ, Beach D 1994 Construction of an improved host strain for two hybrid screening. Nucleic Acids Res 22:1502-3
53. Schiestl RH, Gietz RD 1989 High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet 16:339-46
54. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ 1993 The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7:555-69
55. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases. Cell 75:805-16
56. McLaughlin S, Dixon JE 1993 Alternative splicing gives rise to a nuclear protein tyrosine phosphatase in Drosophila. J Biol Chem 268:6839-42
57. Ayer DE, Kretzner L, Eisenman RN 1993 Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-22